Contact Us

Yes. CAC rescue experiments are well-established for fatty acid oxidation research: • Construct design: use a codon-modified SLC25A20 sequence with a small C-terminal tag (FLAG, HA). CAC has the SLC25 canonical 6-transmembrane architecture with mitochondrial targeting. • Mitochondrial localization validation: confirm mitochondrial inner membrane localization before fatty acid oxidation assays. • CAC deficiency mutation rescue: patient-derived SLC25A20 mutations enable disease genotype-function correlation studies of this severe neonatal disorder. • Functional readout: rescue should restore fatty acid β-oxidation activity measured by ¹⁴C-palmitate oxidation and normalize acylcarnitine profiles. Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation in a hepatic-relevant context for fatty acid metabolism studies.

The choice depends on whether you are studying SLC17A2 (sodium-dependent phosphate transporter)'s role in phosphate handling or its characterization as one of the more poorly-defined SLC17 family members. The Knockout line is appropriate for asking whether SLC17A2 is required for predicted phosphate transport activities, with the caveat that SLC17A2 is less well characterized than other SLC17 family members. Overexpression is useful for substrate identification and transport activity characterization. For SLC17 family research, the EDITGENE SLC17A2 Knockout in Huh-7 enables characterization of this transporter's substrate scope and tissue-relevant functions in hepatic context. Rescue with wild-type SLC17A2 enables initial functional characterization.

Yes, and rescue experiments are particularly important for substrate characterization: • Construct design: use a codon-modified SLC17A2 sequence with a small C-terminal tag (FLAG, HA). The 12-transmembrane SLC17 architecture should be preserved. • Discovery-oriented rescue: parallel rescue with wild-type construct during phenotypic characterization helps distinguish SLC17A2-dependent phenotypes. • Localization validation: confirm subcellular localization by imaging given limited prior characterization. • Functional readout: rescue should restore phenotypes identified during knockout characterization; substrate-specific transport assays test predicted activities. Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC17A9 (VNUT, vesicular nucleotide transporter)'s role in vesicular ATP loading and purinergic signaling or its emerging functions in metabolic disease and cancer. The Knockout line is the standard tool for asking whether VNUT is required for vesicular ATP storage — VNUT is the principal vesicular ATP transporter, essential for purinergic ATP release from many cell types. Overexpression is useful for testing ATP storage capacity or for studying VNUT trafficking. For purinergic signaling research, the EDITGENE VNUT Knockout in Huh-7 enables study of hepatic ATP release and downstream purinergic effects on insulin sensitivity and glucose metabolism. VNUT inhibitors (clodronate, others) specificity testing benefits from this knockout. Rescue with wild-type or transport-deficient VNUT enables structure-function studies. VNUT has emerging therapeutic interest in metabolic disease.

Yes. VNUT rescue experiments require attention to vesicular targeting: • Construct design: use a codon-modified SLC17A9 sequence with a small C-terminal tag (FLAG, HA). VNUT has 12 transmembrane domains. • Vesicular localization validation: confirm secretory vesicle/lysosomal localization by imaging before functional assays. • Transport-deficient rescue: substrate-binding pocket mutations enable structure-function studies of ATP transport. • Functional readout: rescue should restore vesicular ATP storage and stimulated ATP release. Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying RNase H1's role in degrading RNA:DNA hybrids (R-loops) at replication-transcription conflicts or its essential function in mitochondrial DNA replication. The Knockout line is the standard tool for asking whether RNase H1 is required for R-loop resolution and mitochondrial DNA primer removal — RNase H1 is the primary cellular RNase H activity for these processes. Overexpression is useful for studying R-loop biology or for testing RNase H1's role in antisense oligonucleotide mechanism. Important consideration: RNase H1 is essential for mitochondrial DNA replication — complete knockout may impair mitochondrial function and viability. Characterize growth phenotypes before extended use. For R-loop biology research, the EDITGENE RNase H1 Knockout in HEK293 is a standard mechanistic platform. RNASEH1 mutations cause adult-onset autosomal recessive mitochondrial DNA depletion syndrome with Charcot-Marie-Tooth disease (CMT2 phenotype) — disease variant rescue enables genotype-function studies. Rescue with wild-type or catalytically-dead (D210N) RNase H1 is the standard specificity control.

Yes. RNase H1 rescue experiments require attention to dual cellular localization: • Construct design: use a codon-modified RNASEH1 sequence with a small C-terminal tag (FLAG, HA). RNase H1 is expressed from two alternative start codons producing nuclear and mitochondrial isoforms — isoform-specific rescue may be needed. • Catalytically-dead rescue: the D210N mutation in the catalytic site abolishes RNase H activity and is the standard specificity control. • Localization-specific rescue: rescue with nuclear-only or mitochondrial-only RNase H1 enables compartment-specific function dissection. • Functional readout: rescue should restore R-loop resolution (S9.6 immunofluorescence reduction), mitochondrial DNA replication, and ASO-mediated mRNA cleavage activity. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying RHBDF1 (iRhom1)'s role as a broadly expressed regulator of ADAM17/TACE-mediated ectodomain shedding — distinct from iRhom2's more tissue-restricted expression — or its functions in keratinocyte biology and cancer. The Knockout line is the standard tool for asking whether iRhom1 is required for ADAM17 maturation in non-immune cell contexts where it is the dominant iRhom paralog. Overexpression is useful for studying iRhom1's tissue-specific TACE regulation. For ADAM17 regulation research, the EDITGENE RHBDF1 Knockout in HEK293 is a mechanistic platform — iRhom1 is the principal iRhom in many epithelial contexts including HEK293. This product complements the parallel RHBDF1 Knockout in A-549 and the RHBDF1 & RHBDF2 Double Knockouts; HEK293 is preferred for biochemistry and structure-function studies. iRhom1 is essential for ADAM17 ER exit and Golgi maturation — single iRhom1 knockout in HEK293 substantially reduces functional ADAM17. Rescue with wild-type or non-functional iRhom1 variants enables structure-function studies.

Yes. iRhom1 rescue experiments are well-established for ADAM17 trafficking research: • Construct design: use a codon-modified RHBDF1 sequence with a small C-terminal tag (FLAG, HA). iRhom1 has the rhomboid family 7-transmembrane architecture, lacking catalytic activity as a pseudoenzyme. • N-terminal domain mutant rescue: phospho-site mutations enable studies of iRhom1 regulation distinct from iRhom2. • Paralog rescue with iRhom2: rescue interpretation considers RHBDF2 expression — in single iRhom1 KO, residual iRhom2 may partially support ADAM17. • Functional readout: rescue should restore ADAM17 ER exit and Golgi maturation. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying RB1's role as the founding tumor suppressor and master regulator of the G1/S checkpoint or its specific contributions to E2F repression and chromatin modification. The Knockout line is the standard tool for asking whether RB1 is required for restraining E2F-mediated S-phase entry — RB1 is the prototypical tumor suppressor, loss of which leads to uncontrolled E2F target gene expression and cell cycle deregulation. Overexpression is useful for studying RB1 in cancer contexts where it has been reported as a tumor suppressor or for testing constitutively active (phospho-mimetic resistant) RB1 mutants. For tumor suppressor research, the EDITGENE RB1 Knockout in HEK293 is a workhorse mechanistic platform — RB1 loss has been extensively studied in cell cycle biology and cancer. Rescue with wild-type, phosphorylation-resistant (PSM7, 7 CDK site mutations), or hotspot mutant RB1 enables comprehensive structure-function studies. The knockout is valuable for testing CDK4/6 inhibitors (palbociclib, ribociclib, abemaciclib) — RB1 status is a clinical biomarker for CDK4/6 inhibitor response.

Yes. RB1 rescue experiments are well-established for tumor suppressor research: • Construct design: use a codon-modified RB1 sequence with a small C-terminal tag (FLAG, HA). RB1 has N-terminal RbN region, central A and B pocket domains, and C-terminal region — preserve all elements. • Phosphorylation-resistant rescue: PSM7 RB1 (7 CDK phosphorylation site mutations to alanine) is constitutively active (always-bound to E2F) and is invaluable for distinguishing CDK-regulated from constitutive RB1 functions. • Hotspot mutation rescue: cancer-associated RB1 mutations enable disease genotype-function studies. • Functional readout: rescue should restore E2F target gene repression and G1/S checkpoint control. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying PVRIG (CD112R)'s role as an emerging immune checkpoint receptor or its interactions with the PVR family (CD155, CD112, TIGIT, CD96, CD226). The Knockout line is the standard tool for asking whether PVRIG is required for inhibitory signaling on T cells and NK cells — PVRIG binds CD112 (PVRL2/nectin-2) and competes with CD226 (DNAM-1), forming an inhibitory pair analogous to TIGIT-CD155. Overexpression is useful for studying PVRIG signaling or for testing receptor-ligand binding. Important consideration: PVRIG is principally expressed on T cells and NK cells — HEK293 is not the physiological context for PVRIG function. The EDITGENE Knockout in HEK293 is most useful for biochemical and antibody specificity validation work. It serves as a critical negative control for anti-PVRIG antibodies in development as cancer immunotherapy agents (COM701/nelistotug and others). For physiological PVRIG immune signaling research, T cell or NK cell models are more appropriate. Rescue with wild-type or signaling-deficient PVRIG enables structure-function studies.

Yes. PVRIG rescue experiments are well-established for immune checkpoint research: • Construct design: use a codon-modified PVRIG sequence with a small intracellular C-terminal tag (FLAG, HA). PVRIG is a type I membrane protein with an N-terminal Ig-V domain (CD112 binding) and intracellular ITIM/ITT-like motifs — preserve all elements. • Surface localization validation: confirm plasma membrane localization by cell surface staining before functional assays. • Signaling-deficient rescue: cytoplasmic tail ITIM/ITT-like motif mutations enable separation of ligand binding from intracellular inhibitory signaling. • Functional readout: rescue should restore CD112 binding (flow cytometry) and antibody recognition for antibody specificity validation. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying RHBG (Rh family B glycoprotein)'s role as an ammonium transporter or its specific functions in kidney epithelial ammonium handling and acid-base balance. The Knockout line is appropriate for asking whether RHBG is required for cellular ammonium transport — RHBG is principally expressed at basolateral membranes of kidney collecting duct cells, hepatic perivenous hepatocytes, and intestinal epithelium. Overexpression is useful for testing transport activity in heterologous systems or for studying disease-associated mutations. For ammonium transport research, the EDITGENE RHBG Knockout in HCT 116 enables study of intestinal ammonium handling — though renal ammonium transport research benefits from kidney epithelial models. RHCG paralog expression should be assessed given functional overlap. Rescue with wild-type or transport-deficient RHBG is the standard specificity control. The model is valuable for studying ammonium-related acid-base disorders and hepatic ammonia handling pathways.

Yes. RHBG rescue experiments require attention to membrane topology: • Construct design: use a codon-modified RHBG sequence with a small intracellular C-terminal tag (FLAG, HA). RHBG has 12 transmembrane domains — N-terminal tags must not disrupt topology. • Surface localization validation: confirm plasma membrane localization by cell surface biotinylation; basolateral targeting in epithelial cells requires specific signals. • Transport-deficient rescue: substrate-binding pocket mutations enable structure-function studies. • Functional readout: rescue should restore methylammonium uptake activity and ammonium-induced pH dynamics. HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation.